The Latest Surrounding Rising Medicare Part D Premiums
Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.
Reflections on IRA Drug Pricing Negotiations
As the dust settles on the first round of Medicare negotiations, not everything is what it seems.
Who Moved My Prescription? Part VI: Abandonment of Branded Prescriptions
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.